(BPT) - Finding a medication that alleviates major depression can often take months or years: try a dose, wait, adjust, wait again. And for many, antidepressants simply don't provide lasting relief. During that time, symptoms can disrupt work, family life and even basic daily functioning.
A new, non-invasive treatment called SAINT ® (Stanford Accelerated Intelligent Neuromodulation Therapy), licensed exclusively to Magnus Medical from Stanford University, is the first FDA-cleared, clinically proven therapy that provides rapid relief for people with major depressive disorder (MDD).
For those with treatment-resistant major depression — a condition impacting more than half of people with depression who don't respond to medications and psychotherapy — that difference in timing can be lifes